Sicel Cleared for Radiation-Dose Tracker
Posted on: Wednesday, 12 April 2006, 12:00 CDT
Sicel Technologies said it is cleared to market a first-of-its-kind implantable radiation sensor for use in treating cancer.
The new wireless Dose Verification System is used to help physicians determine the actual doses of radiation delivered to a tumor after each course of therapy.
Sicel said it tested the new device in a multi-center clinical trial of breast-cancer patients, the majority of whom were implanted with two of the sensors before undergoing radiation therapy.
The company said the study did not turn up any adverse events linked to the DVS sensor.
We believe DVS represents breakthrough technology that provides significant benefit both to the patient as well as to the oncologist treating the patient, said Sicel President and Chief Executive Officer Michael Riddle. The Company is in the process of completing manufacturing up fit for the device and anticipates beginning to take orders and ship product in the third quarter.
Source: United Press International
Related Articles
- World's First Disposable Wireless RFID Sensor Detects Radiation Threats in Shipping Containers Using Modified Cell Phone Technology
- New HCPCS Reimbursement Code for Implantable Radiation Dosimeter Makes DVS(R) Accessible to More Cancer Patients
- Sicel Technologies Announces Founder Elected Fellow of the American Society for Therapeutic Radiology and Placement of $7MM Convertible Bonds
- Florida Cancer Centers First to Implement Sicel's DVS(R) Implantable Radiation Sensor in the Treatment of Breast and Prostate Cancer
- Sicel Technologies Receives FDA 510(K) Clearance to Expand Use of Its DVS(R) Implantable Radiation Sensor in the Treatment of Prostate Cancer
- Sicel Technologies Receives 510(K) Clearance for DVS(R), the First Implantable Radiation Sensor For Use in Treating Cancer
- Sicel Technologies and CMS Announce Co-Development & Co-Marketing Agreement
- Iraqis Suffer From Radiation Symptoms
- Low-Dose Radiation Harms Cells Longer
 |
 |
User Comments (0)
RSS Feeds